Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Bloomage BioTechnology's Enterprise Value is ¥17,447 Mil.
Bloomage BioTechnology's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ¥275 Mil. Therefore, Bloomage BioTechnology's EV-to-EBIT ratio for today is 63.35.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Bloomage BioTechnology (SHSE:688363) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Bloomage BioTechnology's current Enterprise Value is ¥17,447 Mil.
Bloomage BioTechnology's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥275 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Bloomage BioTechnology's EV-to-EBITDA for today is:
Bloomage BioTechnology's current Enterprise Value is ¥17,447 Mil.
Bloomage BioTechnology's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥275 Mil.
Bloomage BioTechnology's current Enterprise Value is ¥17,447 Mil.
Bloomage BioTechnology's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3,951 Mil.
Bloomage BioTechnology's current Enterprise Value is ¥17,447 Mil.
Bloomage BioTechnology's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥781 Mil.
Bloomage BioTechnology's current Enterprise Value is ¥17,447 Mil.
Bloomage BioTechnology's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥450 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bloomage BioTechnology Enterprise Value Related Terms
Bloomage BioTechnology Enterprise Value Historical Data
* Premium members only.
The historical data trend for Bloomage BioTechnology's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688363 vs LIN, SHW, ECL: Enterprise Value Comparison
For the Specialty Chemicals subindustry, Bloomage BioTechnology's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bloomage BioTechnology Enterprise Value vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Bloomage BioTechnology's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Bloomage BioTechnology's Enterprise Value falls into.
Bloomage BioTechnology Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Bloomage BioTechnology's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bloomage BioTechnology (SHSE:688363) has a Enterprise Value of ¥17,447 Mil as of Jul. 27, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Bloomage BioTechnology and its competitors.
Is Bloomage BioTechnology's Enterprise Value too high?
Bloomage BioTechnology's current Enterprise Value is ¥17,447 Mil. Overall, Bloomage BioTechnology has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bloomage BioTechnology's Enterprise Value compare to LIN and SHW?
Bloomage BioTechnology's Enterprise Value of ¥17,447 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Chemicals company?
A good Enterprise Value depends on the Chemicals industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Bloomage BioTechnology and its competitors. Bloomage BioTechnology's current Enterprise Value is ¥17,447 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bloomage BioTechnology stock overvalued right now?
Based on GuruFocus' analysis, Bloomage BioTechnology (SHSE:688363) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥42.75, compared to a current price of ¥37.55 — trading 12.2% below its estimated fair value. The current Enterprise Value is ¥17,447 Mil. Bloomage BioTechnology's overall GF Score™ is 94/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Bloomage BioTechnology (SHSE:688363), the current Enterprise Value is ¥17,447 Mil as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bloomage BioTechnology (SHSE:688363) Overvalued in 2026?
Based on GuruFocus' analysis, Bloomage BioTechnology stock appears to be undervalued.
The current stock price of ¥37.55 is trading 12.2% below its estimated GF Value™ of ¥42.75.
GuruFocus considers Bloomage BioTechnology to be Modestly Undervalued.
Key valuation signals for SHSE:688363:
Enterprise Value: ¥17,447 Mil
GF Value™: ¥42.75 vs. price of ¥37.55 (12.2% below fair value)
No single metric tells the full story. See the SHSE:688363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bloomage BioTechnology Corp Ltd manufactures and sells a variety of chemicals and chemical-based products, typically made from hyaluronic acid or sodium hyaluronic acid. The company's products include raw materials, medical products, functional skincare, and functional foods. Raw materials, mainly hyaluronic acid, are used in pharmaceuticals, medical devices, cosmetics, and food. Medical products span beauty and therapeutic uses, such as viscoelastics, lubricants, fillers, and skin protectors. Skincare items include lotions, creams, and masks, while functional foods feature hyaluronic acid drinks and supplements.
94GF Score
Get the complete analysis for SHSE:688363
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688363 has been successfully added to your 
